Your browser doesn't support javascript.
loading
Cutaneous-group histiocytoses associated with myeloid malignancies: A systematic review of 102 cases.
Bonometti, Arturo; Gliozzo, Jessica; Moltrasio, Chiara; Bagnoli, Filippo; Berti, Emilio.
Afiliação
  • Bonometti A; Unit of Anatomic Pathology, Department of Molecular Medicine, IRCCS San Matteo Foundation, University of Pavia, Pavia, Italy.
  • Gliozzo J; Department of Dermatology, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.
  • Moltrasio C; Unit of Neuroradiology, IRCCS Ospedale San Raffaele, Milan, Italy.
  • Bagnoli F; Department of Dermatology, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.
  • Berti E; Department of Oncology and Hematology, University of Milan, Milan, Italy.
Australas J Dermatol ; 62(2): e162-e169, 2021 May.
Article em En | MEDLINE | ID: mdl-33125722
ABSTRACT

BACKGROUND:

Histiocytoses are haematological disorders of bone marrow origin that share many biological and clinical features with haematological neoplasms. The association between histiocytoses of the cutaneous-group and myeloid malignancies is a poorly investigated topic of high biological and clinical impact.

METHODS:

We performed a systematic review of the scientific literature, compliant with PRISMA guidelines, to unravel the clinical and pathological features of this intriguing association.

FINDINGS:

We gathered and analysed 102 patients. Most were children with generalised cutaneous eruptions and displayed risk organ involvement (i.e. bone marrow, spleen, liver). Interestingly, all these features are uncommonly encountered in C-group histiocytosis not associated with haematological neoplasms.

CONCLUSIONS:

Our review shows that generalised eruptions and risk organ involvement in cutaneous-group histiocytosis should raise a suspicion for a concomitant myeloid neoplasm both in children and in adults and warrant further investigations. A rapid recognition of this association is required to start a prompt and effective therapeutic management given the aggressive behaviour of the associated myeloid neoplasm in most instances.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Dermatopatias / Histiocitose / Neoplasias Hematológicas Tipo de estudo: Guideline / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Dermatopatias / Histiocitose / Neoplasias Hematológicas Tipo de estudo: Guideline / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article